Research Goals
Our goal is to develop new knowledge regarding the roles of the immune system in health and disease. We further aim to translate this knowledge into novel immunotherapies.
Our laboratory is interested in “Type 2 immunity” in health and disease. Type 2 immunity occurs during allergic diseases or infection with helminth parasites. Nonetheless, emerging data highlight new roles for Type 2 immune responses in metabolism, tissue regeneration and cancer.
We aim to define the roles of type 2 immune responses in chronic inflammation and the tumor microenvironment and to translate these findings into novel immunotherapies.
What's New
Our New paper regarding the effects of the Pfizer vaccine of the spread of SARS-CoV-2 in Israel has just been accepted to Cell Reports Medicine.
Stay Tuned!
Our new study just published online!
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature. Scientific Reports. 2021.;11(1):3461. doi: 10.1038/s41598-021-83019-0
Join us for the next International Eosinophil Society Webinar on April 28th!
Topic: Eosinophils and Airways
Research Programs
Our research program combines state-of-the art approaches including in vivo and in vitro studies, genomics proteomics, molecular biology and imaging.
About our team
We believe that the whole is more than the sum of its parts. We are a highly motivated and collaborative group that is passionate about research!
All Videos
Channel info
People & Blogs, Education
ממלכת ווסטרוז, פרופ' אריאל מוניץ, חיידקים, דלקת, משחקי הכס, אוניברסיטת תל אביב
All Videos
פרופ' אריאל מוניץ: "דלקת: המלחמה האמיתית בממלכת ווסטרוז"
Read more
מתוך אירועי אתנחתא - מסעות בעקבות הלא נודע, 23.5.17Education
אוניברסיטת תל אביב, ממלכת ווסטרוז, משחקי הכס, דלקת, חיידקים, פרופ' אריאל מוניץ
פרופסור אריאל מוניץ
Read more
People & Blogs
Ariel Munitz, Sackler Medical School of the Tel-Aviv University
Read more
Ariel Munitz, Sackler Medical School of the Tel-Aviv University Eosinophils: The Underdog of the Tumor MicroenvironmentPeople & Blogs